Provided by Tiger Trade Technology Pte. Ltd.

Neurosense Therapeutics Ltd

0.8800
-0.0240-2.65%
Pre-market: 0.88000.00000.00%08:00 EST
Volume:69.40K
Turnover:61.60K
Market Cap:29.14M
PE:-2.33
High:0.9098
Open:0.9090
Low:0.8700
Close:0.9040
52wk High:2.60
52wk Low:0.6801
Shares:33.11M
Float Shares:22.11M
Volume Ratio:0.23
T/O Rate:0.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3778
EPS(LYR):-0.5489
ROE:-2478.16%
ROA:-303.90%
PB:-56.15
PE(LYR):-1.60

Loading ...

Apr 05, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 22, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 15, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 15, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 15, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 26, 2023

Correspondence

CORRESP [Cover] - Correspondence
Apr 14, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 02, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Dec 30, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 23, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 20, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 06, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 06, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 06, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Dec 06, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 19, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 19, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Nov 10, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Nov 10, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 04, 2021

Correspondence

CORRESP [Cover] - Correspondence